申请人:Intercept Pharmaceuticals, Inc.
公开号:US20140148428A1
公开(公告)日:2014-05-29
The present invention relates to methods of treating, reducing the risk of preventing, or alleviating a symptom of a pulmonary disease or condition, reducing or suppressing inflammation in the lung, and promoting lung repair, by using a compound of formula A:
or a pharmaceutically acceptable salt thereof.
本发明涉及使用化合物A的方法,用于治疗、减少风险、预防或缓解肺部疾病或状况的症状,减少或抑制肺部炎症,并促进肺部修复,或其药用盐。